Trigger Factor Assisted Soluble Expression of Recombinant Spike Protein of Porcine Epidemic Diarrhea Virus in Escherichia Coli
Overview
Authors
Affiliations
Background: Porcine epidemic diarrhea virus (PEDV) is a highly contagious enteric pathogen of swine. The spike glycoprotein (S) of PEDV is the major immunogenic determinant that plays a pivotal role in the induction of neutralizing antibodies against PEDV, which therefore is an ideal target for the development of subunit vaccine. In an attempt to develop a subunit vaccine for PEDV, we cloned two different fragments of S protein and expressed as glutathione S-transferase (GST)-tagged fusion proteins, namely rGST-COE and rGST-S1D, in E.coli. However, the expression of these recombinant protein antigens using a variety of expression vectors, strains, and induction conditions invariably resulted in inclusion bodies. To achieve the soluble expression of recombinant proteins, several chaperone co-expression systems were tested in this study.
Results: We firstly tested various chaperone co-expression systems and found that co-expression of trigger factor (TF) with recombinant proteins at 15 °C was most useful in soluble production of rGST-COE and rGST-S1D compared to GroEL-ES and DnaK-DnaJ-GrpE/GroEL-ES systems. The soluble rGST-COE and rGST-S1D were purified using glutathione Sepharose 4B with a yield of 7.5 mg/l and 5 mg/l, respectively. Purified proteins were detected by western blot using mouse anti-GST mAb and pig anti-PEDV immune sera. In an indirect ELISA, purified proteins showed immune reactivity with pig anti-PEDV immune sera. Finally, immunization of mice with 10 μg of purified proteins elicited highly potent serum IgG and serum neutralizing antibody titers.
Conclusions: In this study, soluble production of recombinant spike protein of PEDV, rGST-COE and rGST-S1D, were achieved by using TF chaperone co-expression system. Our results suggest that soluble rGST-COE and rGST-S1D produced by co-expressing chaperones may have the potential to be used as subunit vaccine antigens.
Zhuang L, Zhao Y, Shen J, Sun L, Hao P, Yang J Discov Nano. 2025; 20(1):48.
PMID: 40029472 PMC: 11876513. DOI: 10.1186/s11671-025-04220-y.
Li R, Wen Y, Yang L, Qian Q, Chen X, Zhang J BMC Vet Res. 2023; 19(1):46.
PMID: 36765329 PMC: 9921583. DOI: 10.1186/s12917-023-03605-4.
Fatima K, Naqvi F, Younas H Cell Biochem Biophys. 2021; 79(2):153-174.
PMID: 33634426 DOI: 10.1007/s12013-021-00970-5.
Choe S, Song S, Piao D, Park G, Shin J, Choi Y Vet Microbiol. 2020; 242:108604.
PMID: 32122610 PMC: 7117268. DOI: 10.1016/j.vetmic.2020.108604.
Oh S, Kim Cho Y, Lee H, Lee S, Kim W, Hong L J Vet Sci. 2019; 20(6):e70.
PMID: 31775197 PMC: 6883195. DOI: 10.4142/jvs.2019.20.e70.